Case Report | DOI: https://doi.org/BRCA-CR-25-33
Kala-Azar Disease in A 5- Month- Old Male, A Case Report and Review of the Literature
Abstract
Background: Kala azar is a chronic parasitic disease which is prevalent in children such as adults, however, the number of in detail reports about the clinical manifestations, diagnostic methods and the treatment options in small babies are very limited. In this study, an under 6- month- old male and his characteristics have been described.
Case presentation: A five month and 6 days male has admitted to the pediatric ward, because of 12 days’ fever, anorexia, weight loss and weakness. His physical examination findings included malaise and splenomegaly. Remarkable results in his laboratory tests have contained pancytopenia, negative results of all the performed related cultures and serologic tests. The diagnosis has been made by observing the bone marrow smear which included lots of Leishman body as extracellular and intracellular parasites within macrophages. He has responded to daily 3mg/kg Amphotericin B Liposomal for 7 doses as cumulative doses of 21mg/kg without occurring any adverse reactions or recurrence.
Conclusion: It sounds that the clinical presentation, diagnosis and treatment protocols for Kala azar disease in infants should be more studied and reported because of the several challenges this age group of children confronted to, such as different combinations of clinical presentations, diagnostic methods as well as therapeutic protocols.
References
-
Rijal S, Sundar S, Mondal D, et al. Eliminating visceral Leishmaniasis in South Asia: the road ahead. BMJ. 2019; 22,364: k5224
View at Publisher | View at Google Scholar -
Hellenic Center for Disease Control and Prevention. January 2015. Available: http://www.keelpno.gr/
View at Publisher | View at Google Scholar -
Piscopo T V, Azzopardi CM. Leishmaniasis. Postgrad Med J. 2007 ;83(976):649–657
View at Publisher | View at Google Scholar -
Varma N, Naseem S. Hematologic changes in visceral leishmaniasis/Kala azar. Indian J Hematol Blood Transfus. 2010;26(3):78–82
View at Publisher | View at Google Scholar -
Torres-Guerrero E, Quintanilla-Cedillo M R, Ruiz-Esmenjaud J, et al. Leishmaniasis: a review. F1000Res. 2017; 6:750:1-15
View at Publisher | View at Google Scholar -
Karimi A, Alborzi A, Amanati A. Visceral Leishmaniasis: An Update and Literature Review. Archives of Pediatric Infectious Diseases.2016; 4(3); e31612
View at Publisher | View at Google Scholar -
Scarpini S, Dondi A, Totaro C, et al. Visceral Leishmaniasis: epidemiology, diagnosis, and treatment regimens in different geographical areas with a focus on pediatrics. Microorganisms. 2022; 10(10): 1887
View at Publisher | View at Google Scholar -
Mohebali M, Edrissian GH, Akhoundi B, et al. Visceral Leishmaniasis in Iran: an update on epidemiological features from 2013 to 2022. Iran J Parasitol. 2023;18(3):279-293
View at Publisher | View at Google Scholar -
Rostamian M, Bashiri H, Yousefinejad V, et al. Prevalence of human visceral leishmaniasis in Iran: A systematic review and meta-analysis. Comparative Immunology, Microbiology and Infectious Diseases.2021;75, 101604
View at Publisher | View at Google Scholar -
Fakhar M, Rahmati B. Visceral Leishmaniasis in Mazandaran Province and Review on its Current Situation in Iran. J Babol Univ Med Sci. 2011;13(2):68-75
View at Publisher | View at Google Scholar -
Meyerhoff A. US Food and Drug Administration approval of Ambisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Clin Infect Dis. 1999; 28:42–8
View at Publisher | View at Google Scholar -
Krepis P , Argyri J, Krepi A,et al. Short-course regimens of liposomal Amphotericin B for the treatment of mediterranean Visceral Leishmaniasis in children: an 11-year retrospective study at a tertiary care center. Pediatr Infect Dis J. 2017;36(9):849-854
View at Publisher | View at Google Scholar -
Apa H, Devrim I, Bayram N, et al. Liposomal amphotericin B versus pentavalent antimony salts for visceral Leishmania in children The Turkish Journal of Pediatrics 2013; 55: 378-383
View at Publisher | View at Google Scholar -
Karagün B S, Özgür O, Şaşmaz I, et al. Visceral Leishmaniasis in Children in Southern Turkey: Evaluation of Clinical and Laboratory Findings and Liposomal Amphotericin B Treatment. J Pediatr Res. 2019;6(2):110-114
View at Publisher | View at Google Scholar -
Dondi A, Manieri E, Gambuti G, et al. A 10-Year Retrospective Study on Pediatric Visceral Leishmaniasis in a European Endemic Area: Diagnostic and Short-Course Therapeutic Strategies. Healthcare. 2024;12(1), 23;healthcare12010023
View at Publisher | View at Google Scholar -
Melchionda F, Varani S, Carfagnini F, et al. Spleen nodules: a potential hallmark of Visceral Leishmaniasis in young children. BMC Infect Dis. 2014; 14:620
View at Publisher | View at Google Scholar -
Salehi M, Saadati S M, Arzamani K, et al. Some epidemiological feature of human visceral leishmaniasis in North Khorasan Province during 2010-2018. Health Science Monitor. 2024; 3(2): 162-169
View at Publisher | View at Google Scholar -
Pasha F, Saleem S , Nazir T, et al. Visceral Leishmaniasis (Kala-Azar): A Triumph Against a Trickster Disease. Cureus. 2022; 14(6): e25698
View at Publisher | View at Google Scholar -
World Health Organization. Control of the leishmaniases, technical report series. Geneva: World Health Organization; 2010
View at Publisher | View at Google Scholar -
Freire ML, Gonçalves MC, Marques da Silva AC, et al. Serology for visceral leishmaniasis: how trusty is the accuracy reported by the manufacturers? Rev Soc Bras Med Trop. 2023; 20;56: e0358-2022
View at Publisher | View at Google Scholar -
Pandey K, Pal B, Siddiqui N A, et al. Efficacy and safety of liposomal Amphotericin B for Visceral Leishmaniasis in children and adolescents at a tertiary care center in Bihar, India. Am J Trop Med Hyg. 2017;97(5):1498–1502
View at Publisher | View at Google Scholar